| Other Names | Enrofloxacin, 93106-60-6, Baytril, Enrofloxacine, Enrofloxacino, CFPQ, Enrofloxacinum, BAY VP 2674, endrofloxicin, 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-1, 4-dihydroquinoline-3-carboxylic acid, ERFX, MFCD00792463, Enrofloxacinum [Latin], Enroxil, 1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1, 4-dihydro-4-oxo-3-quinolinecarboxylic acid, HSDB 6952, UNII-3DX3XEK1BN, 3DX3XEK1BN, Baytril (TN), N-Ethylciprofloxacin, NSC-758616, BRN 5307824, Enrofloxacin for veterinary use, CCRIS 8214, DTXSID1045619, CHEBI:35720, 3-Quinolinecarboxylic acid, 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1, 4-dihydro-4-oxo-, MLS000069441, DTXCID9025619, Enrofloxacin [USAN:USP:INN:BAN], 1, 4-Dihydro-1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-4-oxo-3-quinolinecarboxylic acid, 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxoquinoline-3-carboxylic acid, NSC 758616, BAY Vp 2674 PD160788, Enrofloxacinum (Latin), NCGC00018143-04, CPD000059011, SMR000059011, 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-quinoline-3-carboxylic acid, ENROFLOXACIN (MART.), ENROFLOXACIN [MART.], 3-Quinolinecarboxylic acid, 1, 4-dihydro-1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-4-oxo-, ENROFLOXACIN (USP-RS), ENROFLOXACIN [USP-RS], Enrofloxacine [French], Enrofloxacino [Spanish], ENROFLOXACIN (USP IMPURITY), ENROFLOXACIN [USP IMPURITY], Enrofloxacin (USAN:USP:INN:BAN), ENROFLOXACIN (USP MONOGRAPH), ENROFLOXACIN [USP MONOGRAPH], Enrofloxacin base, Bay-Vp-2674, 1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1, 4-dihydro-4-oxoquinoline-3-carboxylic Acid, CAS-93106-60-6, Enrofloxacin [USAN:BAN:INN], ENROFLOXACIN FOR VETERINARY USE (EP IMPURITY), ENROFLOXACIN FOR VETERINARY USE (EP MONOGRAPH), ENROFLOXACIN FOR VETERINARY USE [EP IMPURITY], ENROFLOXACIN FOR VETERINARY USE [EP MONOGRAPH], Quellaxcin, Enroflox, Enroquin, Enrosite, Tenotryl, Zobuxa, EnroMed, EnrositeFlavored, FluroxinFlavored, EnrofloxacinFlavored, Enroflox 100, EnroMed 100, Enroquin Antibacterial, SolutionKitsEnrofloxacin, Enrofloxacin (Standard), Enroflox Chewable Tablets, Opera_ID_1106, Enrofloxacin (USP/INN), ENROFLOXACIN [MI], ENROFLOXACIN 100, Enrofloxacin (USAN/INN), ENROFLOXACIN [INN], Fluroxinfor Dogs 2.27%, ENROFLOXACIN [HSDB], ENROFLOXACIN [USAN], 1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-Fluoro-1, 4-Dihydro-4-Oxo-3-Quinolonecarboxylic Acid, Enrofloxacin Flavored Tablets, Baytril Soft Chewable Tablets, MLS001076496, MLS001424169, CHEMBL15511, SCHEMBL149150, SPECTRUM1503721, Baytril 100 Injectable Solution, HY-B0502R, ENROFLOXACIN [GREEN BOOK], HMS2052O09, HMS2090E12, HMS2093I21, HMS2234M11, HMS3373P14, HMS3394O09, HMS3715B18, Pharmakon1600-01503721, ALBB-030792, BCP15457, HY-B0502, Enrofloxacin, >=98.0% (HPLC), Tox21_110831, BBL009982, DL-384, Enroflox Injection for Dogs 2.27%, NSC758616, s3059, STK711109, AKOS005530685, BAY-Vp2674 PD160788, Tox21_110831_1, AC-7614, AE22674, CCG-101102, DB11404, KS-5010, NC00352, 1-cyclopropyl-7-(4-ethylpiperazinyl)-6-fluoro-4-oxohydroquinoline-3-carboxylic acid, Baytril Antibacterial Injectable Solution, NCGC00018143-01, NCGC00018143-02, NCGC00018143-03, NCGC00018143-05, NCGC00021632-03, PD160788, SY052755, SBI-0206725.P001, DB-057368, E0786, Enrofloxacin 1000 microg/mL in Acetonitrile, NS00010889, Enrofloxacin Antibacterial Injectable Solution, D02473, F81544, AB00384269-16, AB00384269_17, AB00384269_18, Enrofloxacin, VETRANAL(TM), analytical standard, Q414413, SR-01000000045, SR-01000000045-3, BRD-K76534306-001-11-0, BRD-K76534306-001-21-9, BRD-K76534306-001-22-7, 1-Cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-1, Enrofloxacin, European Pharmacopoeia (EP) Reference Standard, Enrofloxacin, United States Pharmacopeia (USP) Reference Standard, Baytril Antibacterial Tablets, Baytril Taste Tabs Antibacterial Tablets, Enrofloxacin for system suitability, European Pharmacopoeia (EP) Reference Standard, Enrofloxacin, Pharmaceutical Secondary Standard Certified Reference Material, 1, 4-Dihydro-1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-4-oxo-3-quinolineca rboxyl acid, 1-cyclopropyl-6-fluoro-1, 4-dihydro-4-oxo-7-(4-ethyl-1-piperazinyl)-3-quinoline-carboxylic acid, 1-cyclopropyl-6-fluoro-1, 4-dihydro-4-oxo-7-(4-ethyl-1-piperazinyl)-3-quinolinecarboxylic acid, 1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1, 4-dihydro-4-oxo-3- quinolonecarboxylic acid, 1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1, 4-dihydro-4-oxo-3-quinolineca rboxyl acid, 1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1, 4-dihydro-4-oxo-3-quinolinecarboxylic acid, 9CI, 1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1, 4-dihydro-4-oxo-3-quinolinecarboxylic acid CFPQ Bay vp 2674, 1-CYCLOPROPYL-7-(4-ETHYLPIPERAZINO)-6-FLUORO-4-OXO-1, 4-DIHYDRO-3-QUINOLINECARBOXYLIC ACID |
|---|---|
| IUPAC Name | 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxoquinoline-3-carboxylic acid |
| CAS | 57583-34-3 |
| Molecular Weight | 359.4 |
| Molecular Formula | C19H22FN3O3 |
| SMILES | CCN1CCN(CC1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4CC4)F |

![8-Oxa-3,5-dithia-4-stannatetradecanoic acid,10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-,2-ethylhexyl ester - (57583-34-3)](https://eontrading.uk/wp-content/uploads/2025/04/57583-34-3.png)




